Auspex Pharmaceuticals Receives $84,000,000 New Funding Round

  • Feed Type
  • Date
    2/5/2014
  • Company Name
    Auspex Pharmaceuticals
  • Mailing Address
    3366 North Torrey Pines Court La Jolla, CA 92037
  • Company Description
    Auspex Pharmaceuticals (NASDAQ: ASPX) is a developer of next-generation medicines with improved safety and performance and a pioneer in the targeted application of deuterium chemistry to clinically validated drugs.
  • Website
    http://www.auspexpharma.com
  • Transaction Type
    IPO
  • Transaction Amount
    $84,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

Trending on Xconomy